RaySearch Laboratories AB (publ)
STO:RAY B

Watchlist Manager
RaySearch Laboratories AB (publ) Logo
RaySearch Laboratories AB (publ)
STO:RAY B
Watchlist
Price: 204.5 SEK 0.25%
Market Cap: 7B SEK
Have any thoughts about
RaySearch Laboratories AB (publ)?
Write Note

RaySearch Laboratories AB (publ)
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

RaySearch Laboratories AB (publ)
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
RaySearch Laboratories AB (publ)
STO:RAY B
Additional Paid In Capital
kr2m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
ContextVision AB
OSE:CONTX
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mentice AB
STO:MNTC
Additional Paid In Capital
kr201.4m
CAGR 3-Years
12%
CAGR 5-Years
76%
CAGR 10-Years
N/A
O
Ortivus AB
STO:ORTI B
Additional Paid In Capital
kr32.8m
CAGR 3-Years
0%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Sectra AB
STO:SECT B
Additional Paid In Capital
kr361.5m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
N/A
K
Kontigo Care AB
STO:KONT
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

RaySearch Laboratories AB (publ)
Glance View

Market Cap
7B SEK
Industry
Health Care

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

RAY B Intrinsic Value
219.97 SEK
Undervaluation 7%
Intrinsic Value
Price

See Also

What is RaySearch Laboratories AB (publ)'s Additional Paid In Capital?
Additional Paid In Capital
2m SEK

Based on the financial report for Dec 31, 2023, RaySearch Laboratories AB (publ)'s Additional Paid In Capital amounts to 2m SEK.

What is RaySearch Laboratories AB (publ)'s Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
0%

Over the last year, the Additional Paid In Capital growth was 0%.

Back to Top